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Thymectomy is performed in infants during cardiothoracic surgery leaving many patients with reduced thympopoiesis. An
association between immune disorders and regulatory T cells (Treg) after incidental thymectomy has not been investigated.
Questionnaires soliciting symptoms of atopic or autoimmune disease and biomarkers were measured in children and adults
with congenital heart disease and either reduced or preserved thymopoiesis. Tregs were examined. Atopic or autoimmune-like
symptoms and elevated anti-dsDNA antibodies were common after surgery in individuals with low thymopoiesis. Total Treg
number and function were maintained but with fewer naı¨ve Treg. TCR spectratypes were similar to other memory T cells. These
data suggest that thymectomy does not reduce total Treg number but homeostasis is affected with reduced naı¨ve Treg. Prevalence
of autoimmune or atopic symptoms after surgery is not associated with total number or proportion of Tregs but appears to be due
to otherwise unknown factors that may include altered Treg homeostasis.
1. Introduction
The thymus plays a central role in the generation and main-
tenance of peripheral T-cell populations including those
responsible for modulation of responses to self-antigens [1–
3]. Regulation of immune responses is carried out by a
specific population of T cells termed regulatory T cells (Treg)
[4–6]. These cells carry a distinct phenotype distinguished
by surface expression of CD4, elevated expression of CD25
and intracellular expression of the transcription factor Foxp3
required for suppressive activity [4, 7, 8]. In animal models,
the thymus has been demonstrated to be necessary for
development of Tregs and continued postnatal production is
required to prevent autoimmunity [9].
While the thymus appears to have an essential role in
production of Treg, data suggest that in vivo production of
these cells can occur as a result of activation of peripheral
CD4+ cells by appropriate antigenic stimuli [6, 10–17].
Whether peripheral expansion is adequate to maintain func-
tional Treg populations and prevent autoimmunity in the
absence of thymopoiesis in humans is unknown. The impact
of incidental thymectomy in infancy on the generation and
maintenance of functional Treg is unknown. In many indi-
viduals who have undergone incidental thymectomy during
cardiothoracic surgical repairs in infancy, thymopoiesis is
reduced, often to undetectable levels, compared to those
of individuals without surgery [18]. We observed cases of
atopic and autoimmune disease among children enrolled
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in the prior study leading us to speculate that impaired
production or maintenance of Treg may have a causative
effect. We therefore examined Treg populations in individ-
uals with congenital heart disease to determine the impact of
incidental thymectomy on Treg populations, Treg function,
and incidence of acquired atopic and autoimmune disease.
2. Patients and Methods
2.1. Selection of Study Subjects and Clinical Evaluation.
Subjects with a history of congenital heart disease presenting
for evaluation to the Adult Congenital Heart Disease Clinic
or the pediatric cardiology service at UCLA were invited
to participate. Subjects were excluded if they had a history
of DiGeorge Syndrome or 22q11 chromosomal deletion
(by fluorescence in situ hybridization) or recent or current
infections. An upper age limit of 35 years was chosen to
ensure participation by individuals likely to have under-
gone cardiothoracic surgery during infancy that may have
required sternotomy and resulted in incidental thymectomy.
59 individuals ranging from 3 days to 35 years in age
were enrolled after informed consent was obtained according
to a protocol reviewed and approved by the UCLA Medical
Institutional Review Board. Medical history was obtained
including age, specific congenital cardiac diagnosis, and
history of prior surgical procedures. An additional 5 adult
subjects with no history of congenital heart disease or
cardiothoracic surgery were also recruited and were included
with the No Surgery group (n = 15). Determination of atopic
and autoimmune symptoms was not performed in these
subjects. For most subjects, no details are available regarding
excision of the thymus during prior surgery. However 39
individuals either had radiological imaging (CT or MRI)
of the chest or underwent an initial or repeat surgery for
repair or palliation of congenital heart disease allowing direct
visualization of the anterior mediastinum and the presence
or absence of thymus tissue was noted [19]. Thymus tissue
was reported to be “normal” by gross or histologic evaluation
in all those in whom records of pathologic examination
performed after incidental thymectomy were available.
2.2. Quantitation of TREC and Cellular DNA. Genomic DNA
was extracted from PBMC and TREC were quantified using
real-time polymerase chain reaction (PCR) analysis, using
the 5′ nuclease (TaqMan) assay and the Step One Plus
PCR System (Applied Biosystems) using forward and reverse
primers and probes as previously described [18]. TRECs were
quantified against a standard curve of plasmid containing
signal joint TREC (kindly provided by D. Douek). Subject
classification was accomplished by plotting TREC values for
each subject against age.
2.3. Measurement of Antidouble Stranded DNA. Antidouble
stranded DNA (anti-dsDNA) was measured from plasma
specimens by ELISA (Immco Diagnostics, Buffalo, NY). A
semiquantitative analysis was performed using calibrators
provided and reported as IU/mL of plasma. Subjects less than
6 months of age were excluded from analysis. In addition,
plasma samples from 4 subjects were not suitable for analysis
and these subjects were excluded.
2.4. Identification, Isolation, and Functional Assay of T-Cell
Subsets. Flow cytometry was performed on fresh whole
blood to determine the percentages of CD3+ CD4+ (CD4+
T cells), CD4+ CD27+CD45RA+ (naı¨ve CD4+ T cells),
and CD4+ CD25hi FOXP3+ T cells (Treg) and proportion
of CD4+ CD25hi FOXP3+ Treg that are CD45RA+ or
CD45RA− using fluorochrome conjugated antibodies. Cells
were acquired on a BD FACSCalibur flow cytometer and the
data were analyzed using FLOWJO Software (Treestar Inc.
Ashland, OR). Total lymphocyte number was measured in
the hospital clinical laboratory using automated methods.
For lymphocyte proliferation assay Tregs were isolated from
PBMC using the Miltenyi Biotec MACS (Magnetic Cell
Sorting) (Miltenyi Biotech, Auburn, CA) system according
to manufacturer’s instructions by negative selection of CD4+
T cells and removal of CD45RA+ fraction followed by
isolation of CD4+ CD45RA− CD25+ (designated Treg) and
the CD4+ CD45RA− CD25− (designated CD25−) CD4+
T cell populations. Responder PBMCs were isolated using
Ficoll gradient. For lymphocyte proliferation responding
PBMC were incubated with either the CD25− CD4+ T-
cell populations or Tregs at 3 : 1 and 1 : 1 ratios/well for a
total of 3 × 105 cells for each assay. Samples were incubated
in RPMI medium containing 10% human AB serum and
200 ng/mL of anti-CD3 in triplicate for 6 days at 37◦C.
Tritiated thymidine was added on the 6th day and after 20–24
hours thymidine incorporation was measured and reported
as stimulation index.
2.5. Quantitative Spectratyping for TCR-Vβ Families. Cryo-
preserved PBMCs were sorted on a FACSAria II (BD
Biosciences, San Jose, CA) to isolate the following
populations: CD3+/CD4+/CD45RA+ (naı¨ve), CD3+/
CD4+/CD45RA−/CD25low (memory), and CD3+/CD4+/
CD45RA−/CD25high (Treg) [8]. RNA was isolated using
columns (Qiagen Sciences, MD, 20874). cDNA was gener-
ated using High Capacity cDNA Reverse Transcription Kit
(Applied Biosciences, Foster City, CA) with the addition of
an RNase Inhibitor (Invitrogen Corp, Carlsbad, CA). Real-
time PCR (IQ5, Bio-Rad, USA) and size distribution analysis
were performed for each Vβ family after amplification of
24Vβ families by TaqMan probe-based real-time PCR using
TCR Vβ family-specific forward primer and constant region
reverse primer along with labeled probe. The amplified PCR
products were then resolved by capillary electrophoresis
and the Vβ family specific size peaks were detected based
on the dye-labeled reverse primers (3130 Genetic Analyzer,
Applied Biosystems, USA). The resulting histograms for
each Vβ family were analyzed and the area under the curve
of each size-peak was assessed using Peak Scanner Software
v1.0 (Applied Biosystems). Relative size for each peak was
reported after calculating the ratio of the signal intensity
for the sample peak to reference standard. CDR3 length
distribution for naı¨ve CD4+ T cells for 3 healthy controls
were analyzed and average area determined for each peak of
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all 24 Vβ families was calculated. The sum of absolute error
from this “reference profile” for peaks in all families was
calculated for the entire repertoire as previously described
[32]. The sum of error per Vβ family was calculated to derive
the percent error from the reference distribution. The value
obtained for Tregs was compared to naı¨ve and memory cells
in each group of subjects using Wilcoxon rank sum tests.
2.6. Statistical Analysis. TREC number and T-cell subsets
were treated as continuous variables. Anti-dsDNA antibody
values were subjected to square root transformation prior
to analysis. Individual differences between groups were
analyzed using the Wilcoxon rank-sum test. Associations
between age and naı¨ve CD4+ or Treg subpopulations were
examined using linear regression. The prevalence of symp-
toms inquired about in each organ system was compared
between subject groups using Fisher’s Exact Test. Unadjusted
odds ratio was determined for the presence or absence of
any symptoms (not organ specific) for each group compared
to individuals with no surgery with significance determined
using the Mantel-Haenszel statistic. Multivariable logistic
regression was performed to determine the age adjusted odds
ratio with age as a covariate in subjects with CHD but no
history of surgery as the reference group.
3. Results
3.1. Identification of Subjects with Impaired Thymopoiesis.
Subjects with congenital heart disease aged 2 months to 35
years were examined between 2 months and 34.7 years after
surgery if any was performed. Normal healthy subjects used
for comparison were aged 20 to 29 years old. T-cell recombi-
nation excision circles (TRECs) provide a reliable estimate of
thymopoiesis [21, 22] and were used to identify subjects with
minimal levels of thymopoiesis after cardiothoracic surgery
for analysis. TREC values for all groups including healthy
adult subjects and for those with CHD showed an age-related
decline (Figure 1) and lower values within the subset of
subjects with a history of surgery. Subjects with the lowest
quartile of TREC values were included in the “Prior Surgery-
Low TREC” group (n = 17) if TREC number fell below the
99% confidence interval (CI) of the mean for TREC adjusted
for age (Figure 1). The remaining subjects were grouped
according to surgical history into “No Surgery” or “Prior
Surgery High TREC” groups as appropriate. TREC values
were not different for subjects with CHD and no surgery
(n = 10) and healthy controls (n = 5) (P = .095, ANCOVA);
therefore all subjects with no prior surgery are included in
the “No Surgery” group (n = 15). Subject demographics are
displayed in Table 1.
As expected, all subjects within the “Low TREC” group
have a history of prior surgery and, for those who were
evaluated most had no residual thymus tissue (9 without
versus 2 subjects with residual thymus tissue). Compared to
other subjects who underwent surgery, those with low TREC
more frequently had surgery during infancy (compared to
older age) and a larger proportion underwent two surgeries
or more (compared to a single surgery). Age at 1st surgery
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Figure 1: TREC values versus age for subject classification. Age
adjusted mean and 99% confidence interval for the mean are
displayed. Subjects with TREC values falling below the 99%
confidence interval are included in the “low TREC” group.
was lower for these subjects; time since 1st surgery, age at
last surgery (including those who underwent more than 1
prior procedure), and time since last surgery were similar for
those with prior surgery and low TREC versus high TREC.
We believe that under our classification scheme we have
identified subjects who have significant long-term disruption
to normal de novo T-cell production via thymopoiesis [23–
25]. As seen in previous studies, the absolute number and
percentage of CD4+ T cells was reduced in subjects with
prior surgery and low TREC (data not shown).
3.2. Presence or Absence of Symptoms Is Associated with Prior
Cardiothoracic Surgery. Subjects with CHD were asked to
self-report chronic, frequent, recurrent, or long-standing
symptoms including seasonal or respiratory allergic symp-
toms; asthma; chronic skin rashes; joint pain, redness, or
swelling; chronic or recurrent abdominal pain or diarrhea;
diabetes; or thyroid disorders. The age of onset was also
elicited if subjects could recall. To ensure better homogeneity
among subjects, normal volunteers without congenital heart
disease were excluded from this analysis. One subject did
not complete the questionnaire. Therefore, analysis included
the remaining 58 subjects with CHD. We hypothesized
that older subjects would have a cumulative experience
including more opportunity to develop chronic symptoms
and so analysis was repeated including age as a covariate in
logistic regression and reported as age-adjusted OR (Table 2).
Positive responses were frequent in those having a history of
prior surgery with 63% of subjects reporting the presence
of at least one chronic or longstanding symptom (Table 2).
Subjects with low levels of thymopoiesis were affected more
frequently than those with CHD but no surgery even after
adjustment for age. Of note, skin was most frequently
affected organ, particularly in those with low thymopoiesis
with 7/17 (41%) complaining of symptoms (Table 3),
significantly more often than in those without surgery: no
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Table 1: Characteristics of subjects.
No Surgery Prior Surgery: high TREC Prior Surgery: low TREC
n = 15 (10-CHD; 5-healthy adults) n = 32 n = 17
Age at evaluation (mean years; range)∗ 16.47 (0.2–34.9) 22.6 (1.00–35.7) 18.6 (2.00–34.5)
Healthy adults 26.1 (20.0–29.0)
CHD 12.0 (0.2–34.9) P = .02∧ versus Healty adults
Age at 1st surgery 6.6 (0–28.4) 2.5 (0–13.8) P = .02
∧
versus High TREC
Time since 1st surgery 16.0 (0.2–34.7) 16.1 (1.9–34.0)
Age at last surgery 12.2 (0.01–34.71) 1.4 (0.03–24.4)
Time since last surgery 10.4 (0.1–33.1) 11.0 (0.8–24.3)
Number of surgeries (number of subjects)
0 15 (100%)
1 16 (50%) 5 (29%)
≥2 16 (50% 12 (71%)
Age at initial surgery (number of subjects)
<2 years 13 (41%) 12 (71%)
>2 years 19 (59%) 5 (29%)
Residual thymus (present : absent)∗∗ 6 : 0 12 : 10 2 : 9
Surgery =midline stemotomy.
∗Kruskal-Wallis test = n.s.
∗∗Chi-Square test P = .005.
∧Mann-Whitney test.
subject with CHD who had not undergone surgery reported
any skin symptoms. Among the 14 subjects reporting skin
symptoms, eczema was the single most frequent diagnosis in
5 subjects (2 with high TREC and 3 with low TREC). One
subject reported contact allergy. Six reported the presence
of rash including redness with or without itching or scaling
but with no definite or specific diagnosis given. Data from
population-based studies indicate that the incidence of skin
symptoms in the subjects after surgery is similar to that
reported for atopic and eczematous skin conditions in large
population-based questionnaire studies [26]. While four
subjects in the low TREC group and two in the high TREC
group reported having both skin and joint symptoms, no
subjects reported a diagnosis of systemic lupus erythematosis
(SLE).
Odds of having symptoms were higher in the 19 subjects
lacking thymus tissue (after surgical procedures) to the 20
subjects in whom thymus was present (6 without and 14 with
prior surgery) (OR 4.47; 95% CI 1.19–18.4; P = .027). These
data suggest that thymectomy and level of thymopoiesis are
associated with the development of autoimmune or atopic
symptoms.
3.3. Anti-dsDNA Antibody Titers Are Increased in Patients
with Low TREC. Multiple case reports have suggested an
association of thymectomy to later development of SLE
[27–29] though these reports include patients with myas-
thenia gravis, an autoimmune disorder. Among immune
biomarkers, anti-dsDNA has been associated with autoim-
mune disease, particularly SLE. In order to assess whether
thymectomy itself correlated with levels of this biomarker,
we measured plasma concentration of antibody to double
stranded DNA (dsDNA) in subjects older than 6 months
old (to avoid detection of maternal transplacentally acquired
antibody) with high and low levels of thymopoiesis after
surgery and healthy controls. Antibody levels in subjects with
low thymopoiesis were increased compared to subjects with
no surgery (median 133.6 IU/mL versus 96.5 IU/mL; P =
.03) (Figure 2(a)). To further elucidate this relationship, we
examined antibody levels by age. There was no association
of antibody level with age in subjects with no surgery or
those with a history of prior surgery and higher TREC levels.
However, there is a negative correlation with age in subjects
with low TREC (Figure 2(b)). While there is no statistically
significant relationship between time after surgical procedure
and anti-dsDNA, there is a tendency for levels to decrease
over time possibly accounting for the relationship seen with
age. Thus it appears that production of anti-dsDNA may
be initiated near the time of surgical procedures and levels
diminish with time over the course of years. Interestingly,
level of anti-dsDNA were not associated with the presence
or absence of symptoms nor associated with presence or
absence of residual thymus tissue.
3.4. Total Treg Are Not Dependent on Thymopoiesis for Main-
tenance. We used 4-color flow cytometry to quantify Treg
(see Figure S1 in the supplementary Material available
online at doi: 10.11551 201110915864). Treg were defined
as CD4+/CD25+/Foxp3+ T cells. We quantified both
CD45RA+ and CD45RA− Treg populations. In all subjects
including those with reduced thymopoiesis, the highest
expression of CD25 was present on the CD45RA− Treg
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Table 2: Symptoms reported by subjects with CHD.
Positive responses OR (95% Cl) Age adjusted OR (95% Cl)
No Surgery 2/10 (20%) 1 1
Any surgery (n = 48) 30/48 (63%) 6.67 (1.27–34.9) P = .032 4.88 (.877–27.1) P = .070
High TREC (n = 31) 18/31 (58%) 5.54 (1.01–30.5) P = .067 4.09 (.069–24.5) P = .122
Low TREC (n = 17) 12/17 (71%) 9.60 (1.48–62.1) P = .018 8.47 (1.12–64.3) P = .039
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Figure 2: Anti-dsDNA. (a) Anti-dsDNA antibody levels are displayed. Levels were compared between groups using the Wilcoxon rank sum
test (∗∗P = .03 versus No Surgery; 2-tailed asymptotic). (b) Square root transformed anti-dsDNA levels are plotted by age (left panel) and
time after last surgery (right panel). Associations were examined using linear regression and the significant trendline for the “low TREC”
group is displayed (P = .002, adj R2 = .477). For the other groups there is no significant association between anti-dsDNA level and age or
time since last surgery.
population [7, 8]. There was no relationship between age
and total Treg number or frequency (percent of CD4+ T
cells) among subjects in any group (data not shown). Neither
absolute numbers of CD4+ Treg nor their proportion among
all CD4 T cells differed between groups regardless of history
of surgery or level of thymopoiesis and TREC number
(Figure 3).
Functional capacity was determined for Tregs in a subset
of 5 adolescent and adult subjects (2 with sternotomy during
infancy and no residual thymus, 1 with surgery during
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Figure 3: Quantification of Tregs. Percent and absolute number of CD4+/CD25+/Foxp3+ Tregs are displayed. Groups were compared using
Wilcoxon rank sum with no differences found based on level of thymopoiesis and history of surgery.
Table 3: Symptoms reported by organ or system (number of subjects).
Allergic Gastrointestinal Respiratory Joints Endocrine Skin
No surgery (n = 10 with CHD) 1 (10%) 1 (10%) 0 1 (10%) 0 0
Any surgery (n = 48) 13 (27%) 12 (25%) 8 (17%) 13 (27%) 4 (8%) 15 (31%)
High TREC (n = 31) 9 (29%) 9 (29%) 3 (10%) 8 (26%) 3 (10%) 7 (23%)
Low TREC (n = 17) 4 (24%) 3 (18%) 5 (29%) 5 (29%) 1 (6%) 7 (41%)∗
∗P = .026 versus No Surgery (Fisher exact test).
infancy and residual thymus and high thymopoiesis, and 2
with surgery after infancy and high thymopoiesis, presence
of residual thymus tissue unknown). Proliferation of PBMC
was measured after stimulation with anti-CD3 antibody
without or with the addition of CD25+/CD4+ Treg in 2
concentrations 1 : 1 or 1 : 3 (Treg: PBMC). In each subject,
Tregs had the ability to suppress proliferation of PBMC
in vitro in a dose-dependent manner regardless of history
of sternotomy or thymectomy (Figure 4). Proportion or
absolute Treg was no different between subjects with or
without symptoms after adjusting for age. Similarly, level
of anti-dsDNA was not associated with Treg number or
percentage. Taken together, these data suggest that while
surgery is associated with symptoms commonly found in
autoimmune or atopic disease, alterations in total Treg num-
ber or proportion are not part of the causative mechanism.
3.5. Naı¨ve Treg Populations Are Affected by Age and Thy-
mopoiesis. In total CD4+ T cells, homeostasis of naı¨ve
populations is at least in part due to thymopoiesis. Naı¨ve
(CD45RA+) as a proportion of Treg is highest in infancy
and falls rapidly with age [30]. In our study we investigated
the proportion of naı¨ve Treg and naı¨ve (CD27+/CD45RA+)
CD4+ T cells by age.We find that the proportion of Treg with
a naı¨ve phenotype is associated with age and shows a rapid
decline after infancy accounting for 10–20% of Treg in adults.
In subjects with no prior surgery there is a similar decline
with age for both naı¨ve CD4+ T cells and Treg compared
with subjects with prior surgery and low TREC in whom
the proportion of naı¨ve cells is similar in both adults and
children (Mann-Whitney test) (Figure 5). While total Treg
are maintained in subjects with low TREC, the proportion
of naı¨ve (CD45RA+) to memory cells (CD45RA−) within
the Treg population is affected by surgery, thymectomy, and
level of thymopoiesis. Median proportion of naı¨ve CD4+
and naı¨ve among Tregs are lower in those with low TREC
compared to no surgery both during childhood and in
adolescents/adults. While this could be due to depletion
occurring at the time of surgery, the relationship with age
and similarity to other naı¨ve CD4+ T cells would suggest that
naı¨ve Treg are normally produced via thymopoiesis. When
this process is disturbed, total Treg are maintained by an
active homeostatic process which favors production of cells
with a nonnaive phenotype.
3.6. TCR Spectratype in CD4+/CD25+/CD45RA−Cells Shows
Multiple Expansions. Patterns of TCR Vβ usage have been
examined by others and show unequal usage of different Vβ
families in Treg, but largely similar to total CD4+ T cells
[31, 32]. We wanted to characterize the TCR repertoire of
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Treg after thymectomy and to quantify clonal expansions
within the Vβ families. TCR spectratype was evaluated
in sorted non-naı¨ve Treg (CD4+/CD25+/CD45RA−) and
compared to naı¨ve (CD4+/CD25−/CD45RA+) cells and
memory (CD4+/CD45RA−) T cells. Therefore we were able
to compare a thymus generated (naı¨ve) T-cell population, a
peripherally expanded (memory) population, and non-naı¨ve
Treg. Naı¨ve CD4+ T cells show Gaussian distributions in
most Vβ families, a pattern typically seen in thymus-derived
subpopulations. In contrast, spectratyping demonstrated
perturbations among TCR lengths in many Vβ families in
sorted CD45RA− Treg, indicative of clonal expansions in
peripheral T cell compartments (Figures 6(a) and 6(b)).
As expected, memory CD4+ T cells show perturbations in
TCR spectratype suggestive of multiple clonal expansions in
many Vβ families. The extent of perturbation was quantified
by assessing the error for each Vβ family from a reference
spectratype consisting of the average of 3 naı¨ve CD4+ T-cell
specimens obtained from healthy adults [33]. Average error
from the reference standard in naı¨ve CD4+ was 7.03±0.59%
in healthy adults; 8.20 ± 3.30% for subjects with CHD and
no surgery; 11.9 ± 4.31% for subjects with CHD and prior
surgery (2 with High TREC and 1 with LOW TREC). In
contrast Treg spectratypes contain more error, an average
of 7.68 ± .37% (healthy controls); 14.1 ± 1.99% (CHD no
surgery); 19.2 ± 8.86% (after surgery) (for all P = .028
versus naı¨ve). Memory spectratypes were not statistically
different from Treg (P = .600, Wilcoxon rank-sum).
These data suggest that maintenance of the memory Treg
subpopulation comprising the majority of Treg after infancy
is not dependent on thymic production, but rather is typical
of memory populations and is derived from peripheral
homeostatic proliferation or production of induced Treg.
4. Discussion
Many infants requiring cardiothoracic surgery undergo
incidental thymectomy. Some of the long-term effects on
T-cell production have been described but to date immune
dysregulation has not been fully investigated in these individ-
uals [18, 24, 34, 35]. Studies in animal models have provided
the basis for a number of hypotheses. In day 3 thymectomy
mice, endogenous Treg derived from peripheral replication
are not sufficient to fully control autoimmunity [36]. A
number of investigators have hypothesized that thymus-
derived Treg are distinct from induced Treg derived from
activation and proliferation of CD25−CD4+ T cells in the
periphery [10, 20, 37]. While both types are identified by
similar phenotypic markers (CD4+/CD25+/FoxP3+), they
may differ in functional capacity or specificity and the pres-
ence of both types may be required to perform synergistically
or perform distinct nonoverlapping roles in the maintenance
of self-tolerance and control of autoimmunity [37].
In this study we found evidence of immune dysregu-
lation among the subjects with the most impairment of
thymopoiesis and reduction in number of naı¨ve, thymus-
derived CD4+ T cells and naı¨ve CD4+ Treg. This would
support the hypothesis that thymus-derived Treg are a
distinct population, maintained separately from peripherally
expanded induced Treg with different functional capacity. A
recent study suggests that in addition to production of func-
tional Treg, the thymusmay also be an important contributor
to committed CD4+CD25+Foxp3− Treg precursors, provid-
ing a further mechanism for disruption of homeostasis in
athymic individuals [38]. Potentially, further investigation
could better reveal the thymic versus peripheral origin of
Treg possibly based on compartmentalization of PD-1 or
expression of helios [39, 40]. In addition, subtle disturbance
of positive or negative selection that may occur in these
subjects could not be identified clinically and therefore,
potential effects of selection cannot be ruled out. A number
of groups have suggested that a CD45RA+ phenotype may
be associated specifically with thymus-derived Treg because
the proportion of CD45 RA+ to CD45RA− Treg varies with
age at a similar rate to the decline in thymopoiesis [30, 41].
Furthermore, recent data has shown that Treg that exit the
thymus are exclusively CD45RA+ (Douaisi et al., manuscript
submitted). In the current study, we see an age-related
decline in CD45RA+ Treg, and this effect is exaggerated by
sternotomy, thymectomy, and level of thymopoiesis similar
to the age-related decline in total naı¨ve (non-Treg) CD4+ T
cells in these subjects. Our data tend to confirm that ongoing
thymopoiesis is not a requirement for total Treg homeostasis.
However, homeostasis of naı¨ve Treg is affected by surgery
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Figure 5: Proportion of naı¨ve CD4+ and Tregs. Proportion of CD4+ T cells and Tregs that are naı¨ve (CD27+CD45RA+ or CD45RA+ for
Treg) were examined by age group. In subjects with no surgery, proportion of CD4+ T cells and CD4+ Tregs that are naı¨ve decrease between
childhood and adulthood (P = .007,P = .025; Mann-Whitney test). In subjects with low TREC median proportion of naı¨ve cells is reduced
compared with no Surgery at each age (∗P < .03), but there is no difference between children and adults (P = n.s. for both; Mann-Whitney
test).
and thymopoiesis in a pattern confirming that non-naı¨ve
(CD45RA−) Treg may be produced in the periphery by
proliferation of existing Treg or other CD4+ T cells. Naı¨ve
Tregs appear to be thymus derived resulting in reduction of
this population in our subjects with low TREC and reduced
thymopoiesis.
There may be other possibilities to explain the increased
frequency of chronic symptoms seen in our subjects with
prior surgery and reduced thymopoiesis as compared to
subjects with CHD but no history of surgery. Age differences
alone do not seem to account for this difference as the group
with no surgery shows a similar age distribution to those with
low TREC. In addition the most frequently reported symp-
toms are those suggestive of eczema and atopic dermatitis.
Recent literature provides a wide range for the worldwide
prevalence of eczema and atopic dermatitis among children,
from less than 1% tomore than 20% in childhood during the
peak ages [26]. Prevalence is likely to be lower in adults but
may vary based on ethnicity, nationality, and occupational
exposures [42–46]. Allergic rhinoconjunctivitis is common
in children as well with a prevalence of less than 2% to nearly
40% depending on nation surveyed [26]. Given the wide
variation reported it would be difficult to conclude from
our data that the frequency of symptoms is outside normal
ranges, however given the geographically limited cohort, the
difference between groups should be given consideration.
Eczema and atopic dermatitis tend to occur most frequently
in children with onset by one year of age 60% of the time
[26, 42]. Similarly we found that onset of symptoms, when
they occurred, was frequently during childhood and the
young age of some subjects is unlikely to be the primary
reason for differences between groups. The epidemiology
of this disease has suggested many risk factors including
genetic predisposition and occupational exposures which
were not extensively evaluated in this study. Consequently,
confounding factors have not been adequately addressed and
would deserve further study. The number of subjects with
unoperated CHD is small and may be inadequately powered
to detect differences. However, when analyzed strictly on
the basis of presence or absence of thymus tissue, we
found that subjects without versus those with thymus tissue
report symptoms more frequently suggesting that incidental
thymectomy or related factors are important. Recall bias may
affect the reporting of symptoms, particularly in subjects
who have had surgery and high levels of medical contact
compared to those who have had no surgical procedures.
However except for an earlier age at first surgery, there are no
important demographic differences apparent in those with
higher and lower thymopoiesis that could account for group-
related differences in recall. It is interesting to note case
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Figure 6: Histogram representations of spectratype for CD4+ T-cell subpopulations. Representative data from 2 subjects is displayed.
Distribution of peak lengths for all Vβ families for an 18-year-old with no surgery (a) and a 2-year-old after multiple prior surgeries and
low TREC. (b) Relative Vb lengths for naı¨ve (CD45RA+), memory (CD45RA−), or non-naı¨ve Treg (CD45RA−CD25+) CD4+ T cells are
displayed.
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reports attributing cases of SLE to thymectomy performed
for myasthenia gravis, a disease that itself is thought to
be immune mediated [27–29]. Cardiothoracic surgery and
cardiopulmonary bypass are known to produce short-term
immune activation regardless of thymectomy [47–49]. Long-
term effects have not been described. Immunologic effects
seen in these children and young adults may bemultifactorial
and related to features of surgery in addition to thymectomy.
Further study using more nuanced methods to document
autoimmunity would be useful.
5. Conclusions
Our data suggest that there are long-term immune effects
after cardiothoracic surgeries for repair or palliation of
congenital heart disease that have not been described to date.
While total Treg number is maintained, homeostasis of this
population is affected with unclear affects on autoimmunity.
Subjects with the most impairment in thymopoiesis, typi-
cally those having multiple surgeries beginning in infancy,
correspond to those with elevations in anti-dsDNA antibody
and more self-reported symptoms. As well, these subjects
show evidence of alterations in Treg homoeostasis that may
play a contributory role. The differences we have detected
by the crude measures employed argue for further study
usingmore nuanced clinical diagnostic criteria and expanded
biomarker measurements. Further study of immune dysreg-
ulation in individuals subjected to cardiothoracic surgery,
particularly in infancy, is warranted.
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